Avara Management Ltd
SEC CIK 1814934 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | Dir, 10% | 2.48M | — | $56.30M | 6 | 2022-09-07 | 2023-12-29 |
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Avara Management Ltd made no open-market trades at RPRX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-01-03 | 2023-12-29 | RPRX | Royalty Pharma plc | Avara Management Ltd | Dir, 10% | S - Sale | $28.04 | -65.8K | 2.48M | -3% | -$1.85M |
| MI | 2023-12-15 | 2023-12-13+ | RPRX | Royalty Pharma plc | Avara Management Ltd | Dir, 10% | S - Sale | $28.93 | -672.4K | 3.17M | -18% | -$19.45M |
| I | 2022-12-07 | 2022-12-05 | RPRX | Royalty Pharma plc | Avara Management Ltd | 10% | S - Sale | $43.15 | -84.3K | 7.80M | -1% | -$3.64M |
| I | 2022-09-30 | 2022-09-28 | RPRX | Royalty Pharma plc | Avara Management Ltd | 10% | S - Sale | $41.05 | -32.6K | 8.08M | -0.4% | -$1.34M |
| I | 2022-09-26 | 2022-09-22 | RPRX | Royalty Pharma plc | Avara Management Ltd | 10% | S - Sale | $41.17 | -211.4K | 8.11M | -3% | -$8.70M |
| MI | 2022-09-09 | 2022-09-07+ | RPRX | Royalty Pharma plc | Avara Management Ltd | 10% | S - Sale | $42.70 | -499.5K | 8.58M | -6% | -$21.33M |
Purchase Sale Sale after option exercise All abbreviations